CLINICAL RESEARCH: HEART FAILURE
Renal Impairment and Outcomes in Heart Failure
Systematic Review and Meta-Analysis
Grace L. Smith, MD, MPH*,1,
Judith H. Lichtman, PhD, MPH ,
Michael B. Bracken, PhD, MPH,
Michael G. Shlipak, MD, MPH ,||,
Christopher O. Phillips, MD, MPH¶,
Paul DiCapua, BS* and
Harlan M. Krumholz, MD, SM, FACC*,, ,#,*
* Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut
Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut
General Internal Medicine Section, Medical Service, San Francisco Veterans Affairs Medical Center, San Francisco, California
|| Department of Medicine, University of California, San Francisco, California
¶ Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
# Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut
Manuscript received July 26, 2005;
revised manuscript received November 18, 2005,
accepted November 21, 2005.
* Reprint requests and correspondence: Dr. Harlan M. Krumholz, Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, Sterling Hall of Medicine (SHM), I-Wing, Suite 456, 333 Cedar Street, New Haven, Connecticut 06520. (Email: harlan.krumholz{at}yale.edu).
OBJECTIVES: We estimated the prevalence of renal impairment in heart failure (HF) patients and the magnitude of associated mortality risk using a systematic review of published studies.
BACKGROUND: Renal impairment in HF patients is associated with excess mortality, although precise risk estimates are unclear.
METHODS: A systematic search of MEDLINE (through May 2005) identified 16 studies characterizing the association between renal impairment and mortality in 80,098 hospitalized and non-hospitalized HF patients. All-cause mortality risks associated with any renal impairment (creatinine >1.0 mg/dl, creatinine clearance [CrCl] or estimated glomerular filtration rate [eGFR] <90 ml/min, or cystatin-C >1.03 mg/dl) and moderate to severe impairment (creatinine  1.5, CrCl or eGFR <53, or cystatin-C 1.56) were estimated using fixed-effects meta-analysis.
RESULTS: A total of 63% of patients had any renal impairment, and 29% had moderate to severe impairment. After follow-up 1 year, 38% of patients with any renal impairment and 51% with moderate to severe impairment died versus 24% without impairment. Adjusted all-cause mortality was increased for patients with any impairment (hazard ratio [HR] = 1.56; 95% confidence interval [CI] 1.53 to 1.60, p < 0.001) and moderate to severe impairment (HR = 2.31; 95% CI 2.18 to 2.44, p < 0.001). Mortality worsened incrementally across the range of renal function, with 15% (95% CI 14% to 17%) increased risk for every 0.5 mg/dl increase in creatinine and 7% (95% CI 4% to 10%) increased risk for every 10 ml/min decrease in eGFR.
CONCLUSIONS: Renal impairment is common among HF patients and confers excess mortality. Renal function should be considered in risk stratification and evaluation of therapeutic strategies for HF patients.
|
Abbreviations and Acronyms
| | ACE = angiotensin-converting enzyme | | CI = confidence interval | | CrCl = creatinine clearance | | eGFR = estimated glomerular filtration rate | | HF = heart failure | | HR = hazard ratio | | NYHA = New York Heart Association | | OR = odds ratio | | RR = risk ratio |
|
This article has been cited by other articles:
|
|
|
|
 
T. M. H. Ng, K. A. Ackerbauer, A. F. Hyderi, S. Hshieh, and U. Elkayam
Comparative Effects of Nesiritide and Nitroglycerin on Renal Function, and Incidence of Renal Injury by Traditional and RIFLE Criteria in Acute Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2012;
17(1):
79 - 85.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. Rossignol, J. G. F. Cleland, S. Bhandari, S. Tala, F. Gustafsson, R. Fay, Z. Lamiral, D. Dobre, B. Pitt, and F. Zannad
Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction: Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study
Circulation,
January 17, 2012;
125(2):
271 - 279.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Lopez-Andres, P. Rossignol, W. Iraqi, R. Fay, J. Nuee, S. Ghio, J. G. F. Cleland, F. Zannad, and P. Lacolley
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial
Eur J Heart Fail,
January 1, 2012;
14(1):
74 - 81.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. A. Blair, P. S. Pang, R. W. Schrier, M. Metra, B. Traver, T. Cook, U. Campia, A. Ambrosy, J. C. Burnett Jr, L. Grinfeld, et al.
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial
Eur. Heart J.,
October 2, 2011;
32(20):
2563 - 2572.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. A. Voors, B. A. Davison, G. M. Felker, P. Ponikowski, E. Unemori, G. Cotter, J. R. Teerlink, B. H. Greenberg, G. Filippatos, S. L. Teichman, et al.
Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF
Eur J Heart Fail,
September 1, 2011;
13(9):
961 - 967.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Campo, S. C. Mathai, J. Le Pavec, A. L. Zaiman, L. K. Hummers, D. Boyce, T. Housten, N. Lechtzin, H. Chami, R. E. Girgis, et al.
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
Eur. Respir. J.,
August 1, 2011;
38(2):
359 - 367.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Maisel, C. Mueller, R. Fitzgerald, R. Brikhan, B. C. Hiestand, N. Iqbal, P. Clopton, and D. J. van Veldhuisen
Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial
Eur J Heart Fail,
August 1, 2011;
13(8):
846 - 851.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Manzano-Fernandez, J. L. Januzzi Jr, M. Boronat-Garcia, J. C. Bonaque-Gonzalez, Q. A. Truong, F. J. Pastor-Perez, C. Munoz-Esparza, P. Pastor, M. D. Albaladejo-Oton, T. Casas, et al.
{beta}-Trace Protein and Cystatin C as Predictors of Long-Term Outcomes in Patients With Acute Heart Failure
J. Am. Coll. Cardiol.,
February 15, 2011;
57(7):
849 - 858.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Jie, K. van der Putten, M. W. T. Bergevoet, P. A. Doevendans, C. A. J. M. Gaillard, B. Braam, and M. C. Verhaar
Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome
Heart,
January 1, 2011;
97(1):
60 - 65.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Vranckx, W. Mullens, and J. Vijgen
Chapter 51 Non-pharmacologic therapy of acute heart failure: when drugs alone are not enough
The ESC Textbook of Acute and Intensive Cardiac Care,
December 1, 2010;
1(1):
med-9780199584314-chapter - med-9780199584314-chapter.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Jentzer, T. A. DeWald, and A. F. Hernandez
Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart Failure
J. Am. Coll. Cardiol.,
November 2, 2010;
56(19):
1527 - 1534.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. E. Lassus, M. S. Nieminen, K. Peuhkurinen, K. Pulkki, K. Siirila-Waris, R. Sund, V.-P. Harjola, and for the FINN-AKVA study group
Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome
Eur. Heart J.,
November 2, 2010;
31(22):
2791 - 2798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Butler, D. Chirovsky, H. Phatak, A. McNeill, and R. Cody
Renal Function, Health Outcomes, and Resource Utilization in Acute Heart Failure: A Systematic Review
Circ Heart Fail,
November 1, 2010;
3(6):
726 - 745.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Lee, J. L. Saver, W.-H. Huang, J. Chow, K.-H. Chang, and B. Ovbiagele
Impact of Elevated Cystatin C Level on Cardiovascular Disease Risk in Predominantly High Cardiovascular Risk Populations: A Meta-Analysis
Circ Cardiovasc Qual Outcomes,
November 1, 2010;
3(6):
675 - 683.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Lee, J. L. Saver, K.-H. Chang, H.-W. Liao, S.-C. Chang, and B. Ovbiagele
Low glomerular filtration rate and risk of stroke: meta-analysis
BMJ,
September 30, 2010;
341(sep30_1):
c4249 - c4249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Di Angelantonio, R. Chowdhury, N. Sarwar, T. Aspelund, J. Danesh, and V. Gudnason
Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study
BMJ,
September 30, 2010;
341(sep30_1):
c4986 - c4986.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Hebert, A. Dias, M. C. Delgado, E. Franco, L. Tamariz, D. Steen, P. Trahan, B. Major, and L. M. Arcement
Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population
Eur J Heart Fail,
August 1, 2010;
12(8):
861 - 865.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Campo, S. C. Mathai, J. Le Pavec, A. L. Zaiman, L. K. Hummers, D. Boyce, T. Housten, H. C. Champion, N. Lechtzin, F. M. Wigley, et al.
Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med.,
July 15, 2010;
182(2):
252 - 260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. MacFadyen, M. J. Ng Kam Chuen, and R. C. Davis
Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?
Eur J Heart Fail,
July 1, 2010;
12(7):
649 - 652.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Seegmiller, B. E. Burns, A. H. Fauq, N. Mukhtar, J. C. Lieske, and T. S. Larson
Iothalamate Quantification by Tandem Mass Spectrometry to Measure Glomerular Filtration Rate
Clin. Chem.,
April 1, 2010;
56(4):
568 - 574.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. C. Kane, N. Xu, E. Mistrik, T. Roubicek, A. W. Stanson, and V. D. Garovic
Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis
Nephrol. Dial. Transplant.,
March 1, 2010;
25(3):
813 - 820.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. van der Meer and D. J van Veldhuisen
Anaemia and renal dysfunction in chronic heart failure
Heart,
November 1, 2009;
95(21):
1808 - 1812.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Damman, T. Jaarsma, A. A. Voors, G. Navis, H. L. Hillege, D. J. van Veldhuisen, and on behalf of the COACH investigators
Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH)
Eur J Heart Fail,
September 1, 2009;
11(9):
847 - 854.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. V. Liang, E. L. Greene, A. W. Williams, C. A. Herzog, D. O. Hodge, T. E. Owan, and M. M. Redfield
Exploratory study of relationship between hospitalized heart failure patients and chronic renal replacement therapy
Nephrol. Dial. Transplant.,
August 1, 2009;
24(8):
2518 - 2523.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Kazory and E A Ross
Ultrafiltration for decompensated heart failure: renal implications
Heart,
July 1, 2009;
95(13):
1047 - 1051.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Palmer, T. G. Yandle, C. M. Frampton, R. W. Troughton, M. G. Nicholls, and A. M. Richards
Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction
Eur. Heart J.,
June 2, 2009;
30(12):
1486 - 1494.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Scrutinio, A. Passantino, D. Santoro, E. Cacciapaglia, and G. Farinola
Prognostic value of formulas estimating excretory renal function in the elderly with systolic heart failure
Age Ageing,
May 1, 2009;
38(3):
296 - 301.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Alehagen, U. Dahlstrom, and T. L. Lindahl
Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care
Eur J Heart Fail,
April 1, 2009;
11(4):
354 - 360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kazory and E. A. Ross
Anemia: The Point of Convergence or Divergence for Kidney Disease and Heart Failure?
J. Am. Coll. Cardiol.,
February 24, 2009;
53(8):
639 - 647.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Gheorghiade and P. S. Pang
Acute Heart Failure Syndromes
J. Am. Coll. Cardiol.,
February 17, 2009;
53(7):
557 - 573.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Mullens, Z. Abrahams, G. S. Francis, G. Sokos, D. O. Taylor, R. C. Starling, J. B. Young, and W.H. W. Tang
Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure
J. Am. Coll. Cardiol.,
February 17, 2009;
53(7):
589 - 596.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Komajda, O. Hanon, M. Hochadel, J. L. Lopez-Sendon, F. Follath, P. Ponikowski, V.-P. Harjola, H. Drexler, K. Dickstein, L. Tavazzi, et al.
Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II
Eur. Heart J.,
February 2, 2009;
30(4):
478 - 486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Tsagalis, T. Akrivos, M. Alevizaki, E. Manios, K. Stamatellopoulos, A. Laggouranis, and K. N. Vemmos
Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality
Nephrol. Dial. Transplant.,
January 1, 2009;
24(1):
194 - 200.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Hakeem, S. Bhatti, K. S. Dillie, J. R. Cook, Z. Samad, M. D. Roth-Cline, and S. M. Chang
Predictive Value of Myocardial Perfusion Single-Photon Emission Computed Tomography and the Impact of Renal Function on Cardiac Death
Circulation,
December 9, 2008;
118(24):
2540 - 2549.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E.A. Blair, F. Zannad, M. A. Konstam, T. Cook, B. Traver, J. C. Burnett Jr, L. Grinfeld, H. Krasa, A. P. Maggioni, C. Orlandi, et al.
Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure: Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program
J. Am. Coll. Cardiol.,
November 11, 2008;
52(20):
1640 - 1648.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur. Heart J.,
October 1, 2008;
29(19):
2388 - 2442.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur J Heart Fail,
October 1, 2008;
10(10):
933 - 989.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. F. Groenveld, J. L. Januzzi, K. Damman, J. van Wijngaarden, H. L. Hillege, D. J. van Veldhuisen, and P. van der Meer
Anemia and Mortality in Heart Failure Patients: A Systematic Review and Meta-Analysis
J. Am. Coll. Cardiol.,
September 2, 2008;
52(10):
818 - 827.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Shah, T. Thenappan, S. Rich, L. Tian, S. L. Archer, and M. Gomberg-Maitland
Association of Serum Creatinine With Abnormal Hemodynamics and Mortality in Pulmonary Arterial Hypertension
Circulation,
May 13, 2008;
117(19):
2475 - 2483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Klein, B. M. Massie, J. D. Leimberger, C. M. O'Connor, I. L. Pina, K. F. Adams Jr, R. M. Califf, M. Gheorghiade, and for the OPTIME-CHF Investigators
Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)
Circ Heart Fail,
May 1, 2008;
1(1):
25 - 33.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Amsalem, M. Garty, R. Schwartz, A. Sandach, S. Behar, A. Caspi, S. Gottlieb, D. Ezra, B. S. Lewis, and J. Leor
Prevalence and significance of unrecognized renal insufficiency in patients with heart failure
Eur. Heart J.,
April 2, 2008;
29(8):
1029 - 1036.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Metra, S. Nodari, G. Parrinello, T. Bordonali, S. Bugatti, R. Danesi, B. Fontanella, C. Lombardi, P. Milani, G. Verzura, et al.
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance
Eur J Heart Fail,
February 1, 2008;
10(2):
188 - 195.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. P. Shapiro, T. E. Owan, S. Mohammed, M. Kruger, W. A. Linke, J. C. Burnett Jr, and M. M. Redfield
Mineralocorticoid Signaling in Transition to Heart Failure With Normal Ejection Fraction
Hypertension,
February 1, 2008;
51(2):
289 - 295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. L. Smith, F. A. Masoudi, M. G. Shlipak, H. M. Krumholz, and C. R. Parikh
Renal Impairment Predicts Long-Term Mortality Risk after Acute Myocardial Infarction
J. Am. Soc. Nephrol.,
January 1, 2008;
19(1):
141 - 150.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W.L. Hartog, A. A. Voors, C. G. Schalkwijk, J. Scheijen, T. D.J. Smilde, K. Damman, S. J.L. Bakker, A. J. Smit, and D. J. van Veldhuisen
Clinical and prognostic value of advanced glycation end-products in chronic heart failure
Eur. Heart J.,
December 1, 2007;
28(23):
2879 - 2885.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G.F. Cleland, A. P. Coletta, A. T. Abdellah, K. K. Witte, N. Hobson, and A. L. Clark
Clinical trials update from Heart Rhythm 2007 and Heart Failure 2007: CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT and AREA-IN-CHF
Eur J Heart Fail,
August 1, 2007;
9(8):
850 - 853.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kottgen, S. D. Russell, L. R. Loehr, C. M. Crainiceanu, W. D. Rosamond, P. P. Chang, L. E. Chambless, and J. Coresh
Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study
J. Am. Soc. Nephrol.,
April 1, 2007;
18(4):
1307 - 1315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.H. W. Tang and G. S. Francis
The Year in Heart Failure
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2575 - 2583.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. Coletta, L. Tin, P. H. Loh, A. L. Clark, and J. G.F. Cleland
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902
Eur J Heart Fail,
August 1, 2006;
8(5):
547 - 549.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Renal Dysfunction and Mortality in Heart Failure
Journal Watch Cardiology,
June 22, 2006;
2006(622):
5 - 5.
[Full Text]
|
|
|
|
